Ads
related to: immunology
Search results
On-demand sebetralstat speeds symptom relief in hereditary angioedema, clinical trial finds
Medical Xpress· 14 hours agoMarc A. Riedl, M.D., from the University of California at San Diego in La Jolla...
The 3 Most Undervalued Healthcare Stocks to Buy in June 2024
InvestorPlace· 7 hours agoWhen it comes to seeking discounts, investors may do well with undervalued healthcare stocks. To be...
Melanoma skin cancer vaccine being trialled on NHS halves risk of death or relapse
Daily Telegraph· 1 day agoUsing a cutting-edge technology called an AI-immunology platform, researchers were able to design...
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
Clinical Trials Arena via Yahoo Finance· 6 days agoAt this year’s European Renal Association Congress, positive interim results were presented from...
LJI scientists develop new method to match genes t | Newswise
Newswise· 2 days agoLA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have developed a new...
May M&A deals: Akamai Technologies, DraftKings, Biogen and more - Boston Business Journal
The Business Journals· 3 hours agoSpring is the time of the birds and the bees, but they aren't the only ones keeping busy. Boston's...
An anti-inflammatory curbs spread of fungi causing serious blood infections
Medical Xpress· 6 hours agoC. albicans, or candida, is known to cause yeast infections. In some cases, it develops into...
The role of CAR-T cells in systemic lupus erythematosus
Clinical Trials Arena via Yahoo Finance· 18 hours agoOncology is the leading therapy area of CGT development compared to immunology and musculoskeletal...
BD to acquire Edwards Lifesciences’ Critical Care unit for $4.2bn
Medical Device Network via Yahoo Finance· 17 hours agoIn April this year, BD launched the BD FACSDiscover S8 Cell Sorters worldwide, expanding research...
Vaccination induces broadly neutralizing antibody precursors to HIV gp41 - Nature Immunology
Nature· 6 days agoSchief and colleagues show that germline-targeting epitope scaffolds can elicit responses from rare broadly neutralizing antibody precursor B cells with predefined binding specificities and genetic features.